Internal Medicine Alert - October 30, 2006

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton
Clinical Professor
University of California
Irvine

Associate Editors
Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

Allan J. Wilke, MD
Residency Program Director
Associate Professor of Family Medicine
University of Alabama at Birmingham
School of Medicine?Huntsville Regional
Medical Campus
Huntsville

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky;
Director
Sleep Disorders Center
Samaritan Hospital
Lexington

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Author
Michael Rubin, MD
Professor of Clinical Neurology
NewYork-Presbyterian Hospital
Cornell Campus

Subjects:

  • Cancer or Heart Disease? Drinkers May Need to Choose
  • Exercise and Restless Legs Syndrome
  • The Nose Knows
  • Cluster Headaches
  • Posaconazole Oral Suspension (Noxafil®)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, and associate editors Mary Elina Ferris, MD, Allan J. Wilke, MD, James Chan, PharmD, PhD, and William T. Elliott, MD, FACP report no financial relationship to this field of study. Associate editor Barbara A. Phillips, MD, MSPH serves on the speaker’s bureau of Cephalon, Boehringer Ingelheim, Merck, ResMed, and GlaxoSmithKline, and is a consultant for Boehringer Ingelheim, Wyeth-Ayerst, and ResMed. Author Michael Rubin, MD is on the speaker’s bureau for Athena Diagnostics, and does research for Pfizer and Merck. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.